retatrutide phase 2 nejm 2023 weight loss percent 48 weeks 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Triple hormone receptor agonist retatrutide

429 Precision medicine guided by genetic insights holds promise for tailoring hyperuricemia management to individualized needs

An efficacious treatment for AD has not been forthcoming in part due to the large numbers of potentially important biomarkers, the difficulty in determining their diagnostic reliability and validity, and the multifactorial characteristics of the disease process

Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate

Comprehensive monitoring

Compounded Tirzepatide: A customized formulation of the active ingredient found in Zepbound and Mounjaro, also sourced from FDA-registered and inspected pharmacies